The Spanish Cystic Fibrosis Foundation organised the 5th Cystic Fibrosis Update Day last weekend in Barcelona. The Respiralia Group was represented by Carlos Pons, who was interested in the research projects currently being carried out. Tribute to a lifetime dedicated to Cystic Fibrosis The Spanish Cystic Fibrosis Federation paid tribute to Celestino Raya and Pedro […]
CF
The future of CF treatment lies in a new approach
Professor Marcus Mall from the Christiane Herzog CF Center in Berlin spoke at ERS Congress 2023 about the future of CF treatment being a new therapeutic approach. Challenges ahead for new therapies for cystic fibrosis Dr Mall delved into the research being conducted in people with CF, with a special focus on people with CF […]
The Respiralia Group supports the ERS Tobacco 21 Campaign
The Respiralia Group supports the Tobacco 21 campaign launched by the European Respiratory Society through the European Union. Lung Cancer Awareness Month In this Lung Cancer Awareness Month, the ERS encourages its members to support the “Tobacco 21” campaign and help Europe move towards the end of smoking. The Respiralia Group develops the program “PrevAction: […]
